Demo Sign up Log In

Aquestive Therapeutics Inc (AQST)

Cash Conversion Ratio

0.42×

Quarterly · Period ending: Jun 30, 2026

AQST Cash Conversion Ratio

Latest reported0.42×period endingJun 30, 2026

Latest reported0.42×period endingJun 30, 2026

AQST Quarterly Cash Conversion Ratio (-2.23× → 0.42×)

Latest values, visible window

High-resolution chart · PNG

AQST cash conversion ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Aquestive Therapeutics Inc Cash Conversion Ratio — Quarterly
Period ending	Cash Conversion Ratio
Jun 30, 2026	0.4222×
Mar 31, 2026	1.8441×
Dec 31, 2025	0.2685×
Sep 30, 2025	0.8341×
Jun 30, 2025	0.592×
Mar 31, 2025	1.0264×
Dec 31, 2024	0.3814×
Sep 30, 2024	1.0392×
Jun 30, 2024	2.565×
Mar 31, 2024	0.8117×
Dec 31, 2023	0.6113×
Sep 30, 2023	1.2275×
Jun 30, 2023	1.5078×
Mar 31, 2023	1.0925×
Dec 31, 2022	-0.6817×
Sep 30, 2022	-0.0871×
Jun 30, 2022	0.4441×
Mar 31, 2022	1.1033×
Dec 31, 2021	0.2969×
Sep 30, 2021	0.6285×
Jun 30, 2021	0.1577×
Mar 31, 2021	0.9678×
Dec 31, 2020	0.675×
Sep 30, 2020	0.5046×
Jun 30, 2020	4.3312×
Mar 31, 2020	0.8329×
Dec 31, 2019	0.8437×
Sep 30, 2019	0.8082×
Jun 30, 2019	0.8439×
Mar 31, 2019	1.2261×
Dec 31, 2018	0.2368×
Sep 30, 2018	0.7929×
Jun 30, 2018	0.0032×
Mar 31, 2018	0.1283×
Dec 31, 2017	0.7467×
Sep 30, 2017	1.7979×
Jun 30, 2017	1.2196×
Mar 31, 2017	-2.2313×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.